Unique Metabolomic Signature Associated with Hepatorenal Dysfunction and Mortality in Cirrhosis

The application of non-targeted metabolomic profiling has recently become a powerful non-invasive tool to discover new clinical biomarkers. This study aimed to identify metabolic pathways that could be exploited for prognostic and therapeutic purposes in hepatorenal dysfunction in cirrhosis. One hun...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Transl Res
Autors principals: Mindikoglu, Ayse L., Opekun, Antone R., Putluri, Nagireddy, Devaraj, Sridevi, Sheikh-Hamad, David, Vierling, John M., Goss, John A., Rana, Abbas, Sood, Gagan K., Jalal, Prasun K., Inker, Lesley A., Mohney, Robert P., Tighiouart, Hocine, Christenson, Robert H., Dowling, Thomas C., Weir, Matthew R., Seliger, Stephen L., Hutson, William R., Howell, Charles D., Raufman, Jean-Pierre, Magder, Laurence S., Coarfa, Cristian
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6037419/
https://ncbi.nlm.nih.gov/pubmed/29291380
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trsl.2017.12.002
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars